The IPF COMFORT Study is a clinical research study in patients with coughing attributed to Idiopathic Pulmonary Fibrosis. The investigational drug the study is testing is a once a day tablet called orvepitant. The cough in IPF may be caused by the airways becoming oversensitive, and it is hoped that orvepitant will reduce this over-sensitivity.
The purpose of the IPF COMFORT Study is to see if orvepitant reduces the severity and burden of coughing in people with IPF. The study will also test the safety of orvepitant, how the drug is absorbed and used within the body. Orvepitant is an investigational medicine. This means that it is not approved for sale, but it is but it is approved for use in clinical studies like this one.